Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y. Ho, Eugene Braunwald, Sharlene M. Day et al.|Nature Medicine|2021Cited by 132
Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic CardiomyopathyLauren A. Eberly, Neal K. Lakdawala, Sharlene M. Day et al.|JAMA Cardiology|2019Cited by 109
Fifth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) ReportJoseph W. Rossano, David L.S. Morales, Christina VanderPluym et al.|The Annals of Thoracic Surgery|2021Cited by 98
ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart AssociationAngela Lorts, Daniel Zimpfer, Iki Adachi et al.|The Journal of Heart and Lung Transplantation|2021Cited by 81
Burden of Pediatric Heart Failure in the United StatesShahnawaz Amdani, W.H. Wilson Tang, Bradley S. Marino et al.|Journal of the American College of Cardiology|2022Cited by 66